
|

A focused company:
 |
Business |
|
 |
Speciality Pharmaceuticals
|
|
 |
Proprietary Pharmaceuticals |
|
 |
Orphan Drugs |
|
 |
Branded-Value added first Generics |
 |
Major Therapeutic Areas |
|
 |
Hematology
|
|
 |
Oncology |
|
 |
Neurology |
|
 |
Radiology |
|
 |
Ophtalmology |
|
 |
Orthopedy/Rheumatology |
|
 |
Gynecology |
 |
Functional |
|
 |
In and Out Licensing, Acquisition, Sales&Marketing
|
 |
Geography |
|
 |
Direct and/or Indirect Marketing in several countries
|
| |
|
- Biem has several hospital products that are well established in the segments we focus on i.e Hematology, Oncology and Radiology.
- Our team has considerable experience in the healthcare and pharmaceutical markets, which encompasses the Pharmacy and General Practice markets as well as hospital.
- Biem Pharmaceuticals is dedicated to marketing
niche pharmaceutical products to the TR market.
- Biem acquires and license these innovative
products from multinational and development companies.
- Biem is well positioned to partner with other companies to successfully commercialise products in a wide range of therapeutic areas and market settings.
- Biem has a dedicated team committed to ensuring success, particularly in niche markets that are less attractive to multinational corporations.
|
When out-licensing or divesting a product you need to know it is going to a safe pair of hands. At Biem we provide full support across sales and marketing, regulatory affairs, manufacturing transfer, medical affairs, product development and distribution.
|